Pestszentimrei Gyermekrendelo
- Address
- lock Available on a paid plan
Pestszentimrei Gyermekrendelo - Pediatric Vaccine Research Center
Pestszentimrei Gyermekrendelo is a specialized pediatric clinical research facility in Hungary dedicated to advancing vaccine research and immunization strategies in children and adolescents. The center participates in multinational studies evaluating long-term vaccine efficacy and immune protection in pediatric populations.
- Meningococcal vaccine immunogenicity and long-term persistence studies
- Pediatric and adolescent booster vaccination programs
- Multi-year longitudinal vaccine surveillance research
The center demonstrates particular expertise in evaluating quadrivalent meningococcal conjugate vaccines and their effectiveness across extended time periods. Their research focuses on assessing immune persistence and vaccine seroresponse following primary immunization and subsequent booster doses in children who received initial vaccinations as toddlers. This work contributes valuable data on optimal vaccination schedules and the duration of protection against meningococcal infection across different pediatric age groups, supporting evidence-based immunization policies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pestszentimrei Gyermekrendelo
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Immunogenicity and Safety of MenACYW Conjugate Vaccine Booster in Pediatric and Adolescent Populations with Prior Vaccination | Sanofi Pasteur | Phase III | Not Recruiting | Aug 2022 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid | 1 | Unknown | 2022-08-23 | 2022-08-23 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.